Advanced Proteome Therapeutics Corporation
APCH.V
TSX
| 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -187.30K | -174.30K | -214.40K | -263.70K | -59.80K |
| Depreciation & Amortization | -2.90K | -3.00K | -3.00K | -3.00K | -900.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 925.50K | 1.01M | 995.50K | 941.10K | 850.30K |
| Operating Income | -925.50K | -1.01M | -995.50K | -941.10K | -850.30K |
| Income Before Tax | -2.21M | -1.22M | -300.80K | 597.50K | 849.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.21 | -1.22 | -0.30 | 0.60 | 0.85 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 168.70K | 185.90K | 174.80K | 162.10K | 136.70K |
| Net Income | -2.04M | -1.03M | -125.90K | 759.60K | 986.60K |
| EBIT | -925.50K | -1.01M | -995.50K | -941.10K | -850.30K |
| EBITDA | -921.80K | -1.01M | -990.90K | -936.60K | -845.70K |
| EPS Basic | -0.05 | -0.03 | 0.00 | 0.02 | 0.03 |
| Normalized Basic EPS | -0.01 | -0.01 | 0.00 | 0.01 | 0.02 |
| EPS Diluted | -0.05 | -0.03 | 0.00 | 0.02 | 0.03 |
| Normalized Diluted EPS | -0.01 | -0.01 | 0.00 | 0.01 | 0.02 |
| Average Basic Shares Outstanding | 160.38M | 159.35M | 157.55M | 155.62M | 153.67M |
| Average Diluted Shares Outstanding | 160.38M | 159.35M | 157.55M | 155.62M | 153.67M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |